Literature DB >> 3183129

MR imaging of intrasellar meningiomas simulating pituitary adenomas.

A S Michael1, M L Paige.   

Abstract

Over 3 1/2 years, 401 magnetic resonance studies were performed for suspected sellar-parasellar masses. Twenty-nine pituitary macroadenomas and 12 meningiomas were detected. Among the meningiomas there were three whose MR appearance simulated that of a pituitary tumor. In none of these cases was the diaphragma sellae visualized. Furthermore, in one case the prolactin level was elevated. A preoperative diagnosis of pituitary tumor resulted in an inappropriate surgical approach being used initially for its removal (transsphenoidal). Thus, nonvisualization of the diaphragma sellae and elevated prolactin levels do not exclude a nonpituitary origin of a sellar-parasellar tumor. Other methods for preoperative differentiation are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3183129     DOI: 10.1097/00004728-198811000-00007

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  Intrasellar meningioma: characteristic imaging findings.

Authors:  H Satoh; K Arita; K Kurisu; M Sumida; T Nakahara; K Eguchi; K Kuroki
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

2.  MRI of an unenhancing tuberculum sellae meningioma.

Authors:  M Sintini; M Frattarelli; L Mavilla
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

3.  Clinical features of sellar and suprasellar meningiomas.

Authors:  Ratchaneewan Kwancharoen; Ari M Blitz; Fabiana Tavares; Patrizio Caturegli; Gary L Gallia; Roberto Salvatori
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

4.  Evidence-based treatment of cavernous sinus meningioma.

Authors:  Javad Hekmatpanah
Journal:  Surg Neurol Int       Date:  2019-11-22

5.  Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC.

Authors:  Jing Zhang; Zhiyong Zhao; Li Dong; Tao Han; Guojin Zhang; Yuntai Cao; Junlin Zhou
Journal:  Endocr Connect       Date:  2020-12       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.